A Population Genetics Laboratory
From 1791 until its formal abolition in 1917, the Russian Empire enforced a policy of residential restriction for its Jewish population. This territory, known as the Pale of Settlement, covered approximately 1 million square kilometers (386,000 square miles) across what is now Belarus, Lithuania, Moldova, Ukraine, and parts of Poland. By the end of the 19th century, this area contained about five million Jews, representing over 90% of all Jews in Russia and a significant portion of the world's Jewish population at the time. The law confined a massive, growing population within a fixed boundary, creating a unique scenario for population genetics.
This long-term geographic and social isolation intensified the effects of pre-existing genetic patterns within the Ashkenazi Jewish population. Genetic studies indicate that the Ashkenazi population already descended from a small founding group, a phenomenon known as a founder effect. The restrictions of the Pale limited gene flow from non-Jewish populations and promoted endogamy (marriage within the group), turning the region into a large-scale, long-term case study in genetic drift. Genetic drift is the random fluctuation of gene variant frequencies in a population.
The Founder Effect Amplified
A founder event occurs when a new population is established by a very small number of individuals, whose gene pool may differ by chance from the source population. Research suggests that much of the Ashkenazi population descends from a small medieval group, with some studies pointing to as few as four maternal lineages accounting for a large percentage of mitochondrial DNA. Within the confines of the Pale, rare genetic variants present in the founders became more common over generations.
This process explains the higher prevalence of certain autosomal recessive disorders among Ashkenazi Jews. For a recessive condition to appear, an individual must inherit a copy of the mutated gene from both parents. In a large, diverse population, the chances of two carriers meeting are low. In a genetically isolated population descended from a small number of founders, those chances increase substantially.
This genetic pattern is observable in the carrier rates for specific conditions. For Tay-Sachs disease, a fatal neurodegenerative disorder, the carrier frequency in the Ashkenazi population is about 1 in 27, compared to approximately 1 in 250 in the general population. Gaucher disease (Type 1), a lysosomal storage disorder, is the most common genetic disease affecting this group, with a carrier rate of about 1 in 10, dramatically higher than the 1 in 100 to 1 in 200 rate in non-Jewish populations.